Literature DB >> 15315156

Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.

Qiurong Ruan1, Yuchang Hu.   

Abstract

To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA), immunohistochemical SP method was used to detect expressions of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 in paraffin-embedded tissues of 18 cases of MEM, 20 OA and 20 CA. The results showed that there was a significant difference in the expressions of E-cadherin, CA19-9 and MOC-31 between MEM and OA group (P<0.05). Similarly, the difference in the expression of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 between MEM and CA groups is significant (P<0.05). These results indicate that HBME-1 could be used as a positive marker in distinguishing MEM from CA. E-cadherin, CA19-9 and MOC-31 are considered to be useful negative markers in diagnostic distinction between MEM and metastatic adenocarcinomas, including OA and CA. CK7 is the best positive marker in distinguishing MEM from CA, but this marker appears to be valueless in discriminating MEM from OA.

Entities:  

Mesh:

Year:  2004        PMID: 15315156     DOI: 10.1007/bf02885405

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  An autopsy case of a malignant pericardial mesothelioma in a Japanese young man.

Authors:  M Watanabe; H Suzuki; K Fukutome; A Enoki; N Yamada; T Nakano; T Shiraishi; R Yatani
Journal:  Pathol Int       Date:  1999-07       Impact factor: 2.534

2.  Primary malignant gonadal mesotheliomas and asbestos.

Authors:  R L Attanoos; A R Gibbs
Journal:  Histopathology       Date:  2000-08       Impact factor: 5.087

Review 3.  Cadherin cell adhesion receptors as a morphogenetic regulator.

Authors:  M Takeichi
Journal:  Science       Date:  1991-03-22       Impact factor: 47.728

Review 4.  Immunophenotyping of malignant mesothelioma.

Authors:  M R Wick
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

5.  Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma.

Authors:  R L Attanoos; H Goddard; A R Gibbs
Journal:  Histopathology       Date:  1996-09       Impact factor: 5.087

6.  Antigens of small-cell lung cancer. First International Workshop.

Authors:  R L Souhami; P C Beverley; L G Bobrow
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

7.  Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.

Authors:  A C Han; A Peralta-Soler; K A Knudsen; M J Wheelock; K R Johnson; H Salazar
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

8.  Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary.

Authors:  G Ueda; M Sawada; H Ogawa; O Tanizawa; M Tsujimoto
Journal:  Gynecol Oncol       Date:  1993-11       Impact factor: 5.482

Review 9.  Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.

Authors:  N G Ordóñez
Journal:  Am J Surg Pathol       Date:  1998-10       Impact factor: 6.394

10.  OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

Authors:  C Edwards; J Oates
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.